The MITO8 phase III international multicenter randomized study testing the effect on survival of prolonging platinum-free interval (PFI) in patients with ovarian cancer (OC) recurring between 6 and 12 months after previous platinum-based chemotherapy: A collaboration of MITO, MANGO, AGO, BGOG, ENGOT, and GCIG.-Reference-Cited by-同舟云学术

The MITO8 phase III international multicenter randomized study testing the effect on survival of prolonging platinum-free interval (PFI) in patients with ovarian cancer (OC) recurring between 6 and 12 months after previous platinum-based chemotherapy: A collaboration of MITO, MANGO, AGO, BGOG, ENGOT, and GCIG.

Published:2016-05-20 Issue:15_suppl Volume:34 Page:5505-5505
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pignata Sandro¹,Scambia Giovanni²,Raspagliesi Francesco³,Murgia Viviana⁴,Pisano Carmela¹,Salutari Vanda²,Bologna Alessandra⁵,Sorio Roberto⁶,Ferrandina Gabriella⁷,Sacco Cosimo⁸,Vergote Ignace⁹,Cormio Gennaro¹⁰,Breda Enrico¹¹,Cinieri Saverio¹²,Cecere Sabrina Chiara¹,Wagner Uwe A. G.¹³,Daniele Gennaro¹,Gallo Ciro¹⁴,Perrone Francesco¹,Piccirillo Maria Carmela¹

Affiliation:

1. Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione Pascale, IRCCS, Napoli, Italy;

2. Universita Cattolica del Sacro Cuore di Roma, Unità di Ginecologia Oncologica UOC, Rome, Italy;

3. Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy;

4. Santa Chiara Hospital, Trento, Italy;

5. Medical Oncology Unit, IRCCS-Arcispedale S. Maria Nuova, Reggio Emilia, Italy;

6. Centro di Riferimento Oncologico-IRCCS, Aviano, Italy;

7. Centro di Ricerca e Formazione ad Alta Tecnologia nelle Scienze Biomediche, Università Cattolica del Sacro Cuore, Campobasso, Italy;

8. Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria S. M. della Misericordia, Udine, Italy;

9. Universitaire Ziekenhuizen UZ Leuven, Leuven, Belgium;

10. University of Bari, Bari, Italy;

11. S. Giovanni Calibita- Fatebenefratelli Hospital, Roma, Italy;

12. Sen Antonio Perrino Hospital, Francavilla Fontana, Italy;

13. Philipps Univ Marburg, Marburg, Germany;

14. Seconda Università, Napoli, Italy;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.5505

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-07-05

2. Diagnosis and Management of Epithelial Ovarian Cancer;Handbook of Gynecology;2023

3. Diagnosis and Management of Epithelial Ovarian Cancer;Handbook of Gynecology;2023

4. Cáncer de ovario;Medicine - Programa de Formación Médica Continuada Acreditado;2021-03

5. A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer;International Journal of Gynecological Cancer;2018-07